Skip to main content
. 2014 Jun 5;9(11):2006–2013. doi: 10.2215/CJN.01330214

Figure 1.

Figure 1.

Pathways leading from genetic susceptibility to clinical kidney disease. APOL1, apolipoprotein L1 gene; BMP4, bone morphogenetic protein 4; HAART, highly active antiretroviral therapy; HIVAN, HIV-associated nephropathy; NPHS2, podocin; SDCCAG8, serologically defined colon cancer antigen 8.